revenue due to the decrease in consumers’ purchasing power as a result of the impact from the new wave of COVID-19 outbreak, as well as the temporary closure of some branches according to government
1Q22 MD&A Advanced Info Service Plc. Executive Summary Prolonged economic impact from Omicron outbreak and rising inflation in 1Q22 In 1Q22, Thailand’s economic recovery was challenged as private
Executive Summary and Management Guidelines to Mitigate the Effects of the COVID-19 Outbreak 03 Statement of Income 09 Business Performance 11 Statement of Financial Position 24 Cash of Statement 26 Financial
the COVID-19 Outbreak 03 Statement of Income 09 Business Performance 11 Statement of Financial Position 24 Cash of Statement 26 Financial Ratios 27 Environment Management Accounting 29 3 Management
-19 Outbreak 03 Statement of Income 09 Business Performance 11 Statement of Financial Position 24 Cash of Statement 26 Financial Ratios 27 Environment Management Accounting 29 3 Management Discussion
2017. The details are as follow : Unit : Million baht 2018 2017 Dividend received from - The company in SET 140.17 178.62 - The Medic Pharma Co.,Ltd. 0.86 0.86 - Buranavetch Co.,Ltd. 5.70 5.70 - Thai
-0135 www.interpharma.co.th Inter Pharma Public Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th IP_AC
Ranking IRC INOUE RUBBER (THAILAND) PUBLIC COMPANY LIMITED Filing FinancialStatement 56-1 56-2 Ranking IVF INSPIRE IVF Public Company Limited Filing FinancialStatement 56-1 56-2 Ranking IP INTER PHARMA
Inter Pharma Public Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th IP_OCS/009/2562 วนัท่ี 4